PMID- 31884848 OWN - NLM STAT- MEDLINE DCOM- 20210514 LR - 20220531 IS - 1473-2300 (Electronic) IS - 0300-0605 (Print) IS - 0300-0605 (Linking) VI - 48 IP - 4 DP - 2020 Apr TI - Activation of autophagy during farnesyl pyrophosphate synthase inhibition is mediated through PI3K/AKT/mTOR signaling. PG - 300060519875371 LID - 10.1177/0300060519875371 [doi] LID - 0300060519875371 AB - OBJECTIVES: Autophagy is divided into three phases: autophagosome engulfment of intracellular organelles and proteins, autophagosome fusion with lysosomes, and autolysosome degradation. The farnesyl pyrophosphate synthase inhibitor ibandronate (IBAN) has in vivo cardioprotective properties, potentially via anti-oxidant effects. Whether autophagy is involved in the cardioprotective effect of IBAN remains unexplored. METHODS: Human umbilical vein endothelial cells (HUVECs) were treated in vitro with IBAN to assess autophagy induction. Lysosomal activation and phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signaling were assessed using a LysoTracker assay, acridine orange staining and western blotting. An MTS assay was used to assess cellular proliferation. Autophagy was inhibited using chloroquine or RNA silencing of autophagy-related 7 (Atg7) expression. RESULTS: IBAN induced autophagy in HUVECs. Moreover, IBAN activated lysosomal function, which is pivotal to autophagy induction. PI3K/AKT/mTOR activity was inhibited in IBAN-treated HUVECs, indicating the involvement of this pathway in IBAN-induced autophagy. Inhibition of autophagy using either chloroquine or Atg7 siRNA potentiated inhibition of HUVEC growth by IBAN, suggesting the involvement of non-autophagy pathways in the antiproliferative effects of IBAN. CONCLUSIONS: These findings provide insights into the role of autophagy in the cardioprotective effects of IBAN and the molecular mechanisms underlying autophagy induction by IBAN. FAU - Han, Jie AU - Han J AD - Department of Cardiology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. FAU - Huang, Chaoyang AU - Huang C AD - Department of Cardiology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. FAU - Jiang, Jiukun AU - Jiang J AD - Department of Emergency, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. FAU - Jiang, Dongmei AU - Jiang D AUID- ORCID: 0000-0002-7926-8645 AD - Department of Cardiology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. LA - eng PT - Journal Article DEP - 20191229 PL - England TA - J Int Med Res JT - The Journal of international medical research JID - 0346411 RN - 0 (Polyisoprenyl Phosphates) RN - 0 (Sesquiterpenes) RN - EC 2.5.1.10 (Geranyltranstransferase) RN - EC 2.7.1.1 (MTOR protein, human) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) SB - IM MH - Apoptosis MH - *Autophagy MH - Geranyltranstransferase/*antagonists & inhibitors MH - Humans MH - Phosphatidylinositol 3-Kinases/genetics MH - Polyisoprenyl Phosphates MH - Proto-Oncogene Proteins c-akt/genetics MH - Sesquiterpenes MH - *Signal Transduction MH - TOR Serine-Threonine Kinases/genetics PMC - PMC7607048 OTO - NOTNLM OT - Atg7 OT - Autophagy OT - FPPS OT - HUVECs OT - IBAN OT - mTOR COIS- The authors declare that there are no conflicts of interest. EDAT- 2019/12/31 06:00 MHDA- 2021/05/15 06:00 PMCR- 2019/12/29 CRDT- 2019/12/31 06:00 PHST- 2019/12/31 06:00 [pubmed] PHST- 2021/05/15 06:00 [medline] PHST- 2019/12/31 06:00 [entrez] PHST- 2019/12/29 00:00 [pmc-release] AID - 10.1177_0300060519875371 [pii] AID - 10.1177/0300060519875371 [doi] PST - ppublish SO - J Int Med Res. 2020 Apr;48(4):300060519875371. doi: 10.1177/0300060519875371. Epub 2019 Dec 29.